Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1377-1382

  Crnković Mertens, Irena ^a   Messerle, Martin ^a   Milotić, Irena ^b   Szepan, Uwe ^a   Kučić, Natalija ^b   Krmpotić, Astrid ^b   Jonjić, Stipan ^b   Koszinowski, Ulrich H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GENE PRODUCT; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERTANT; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 2642611097     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1377-1382.1998     Document Type: Article

References (42)

1. Baucke, R. B., and P. G. Spear. 1979. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32:779-789.
2. Beersma, M. F. C., M. J. E. Bijlmakers, and H. L. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I heavy chains. J. Immunol. 51:4455-4464.
3. Card, J. P., M. E. Whealy, A. K. Robbins, and L. W. Enquist. 1992. Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J. Virol. 66:3032-3041.
4. Cavanaugh, V. J., R. M. Stenberg, T. L. Staley, H. W. Virgin IV, M. R. McDonald, S. Paetzold, H. E. Farrell, W. D. Rawlinson, and A. E. Campbell. 1996. Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism. J. Virol. 70:1365-1374.
5. 134.5, a gene nonessential for growth in culture. Science 250:1262-1266.
6. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldman. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (London) 312:548-551.
7. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. K. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145-1153.
8. Dingwell, K. S., C. R. Brunetti, R. L. Hendricks, Q. Tang, M. Tang, A. J. Rainbow, and D. C. Johnson. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68:834-845.
9. Dingwell, K. S., L. C. Doering, and D. C. Johnson. 1995. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69: 7087-7098.
10. Dowler, K. W., and R. W. Veltri. 1984. In vitro neutralisation of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J. Med. Virol. 13:251-259.
11. Dubin, G., E. Socolof, I. Frank, and H. M. Friedman. 1991. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:7046-7050.
12. Farell, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (London) 386:510-514.
13. Frank, I., and H. M. Friedman. 1989. A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 63:4479-4488.
14. Friedman, H. M., G. H. Cohen, R. J. Eisenberg, C. A. Siedel, and D. B. Clines. 1984. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the complement component C3b on infected cells. Nature (London) 309: 633-635.
15. Gooding, L. R. 1992. Virus proteins that counteract host immune defences. Cell 71:5-7.
16. Gu, H., Y. R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164.
17. Jones, T. R., K. Hanson, L. Sun, S. Slater, R. M. Stenberg, and A. E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830-4841.
18. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of reccurent virus. J. Exp. Med. 179:1713-1717.
19. Keller, R., R. Peitchel, J. N. Goldman, and M. Goldman. 1976. An IgG-Fc receptor induced in cytomegalovirus infected fibroblasts. J. Immunol. 116: 772-777.
20. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature (London) 350:423-426.
21. Koo, G. C., F. J. Dumond, M. Tutt, J. Hackett, and V. Kumar. 1986. The NK 1.1-mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742-3747.
22. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-497.
23. Lagenaur, L. A., W. C. Manning, J. Viera, C. L. Martens, and E. S. Mocarski. 1994. Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J. Virol. 68:7717-7727.
24. Litwin, V., W. Jackson, and C. Grose. 1992. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66:3643-3651.
25. Maidji, E., S. Tugizov, T. Jones, Z. Zheng, and L. Pereira. 1996. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J. Virol. 70:8402-8410.
26. Maniatis, T., E. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
27. Manning, W. C., C. A. Stoddart, L. A. Langenaur, G. B. Abenes, and E. S. Mocarski. 1992. Cytomegalovirus determinant of replication in salivary glands. J. Virol. 66:3794-3802.
28. McFadden, G., and K. Kane. 1994. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv. Cancer Res. 63:117-209.
29. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
30. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
31. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. Strominger. 1997. The class I homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature (London) 386:514-518.
32. Sauer, B., and N. Henderson. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85:5166-5170.
33. Sears, A. E., I. W. Halliburton, B. Maigneir, S. Silver, and B. Roizman. 1985. Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J. Virol. 55:338-346.
34. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. Buller, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152.
35. Stenberg, N., and D. Hamilton. 1981. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol. 150:467-486.
36. Stoddart, C. A., R. D. Cardin, J. M. Boname, W. C. Manning, G. B. Abenes, and E. S. Mocarski. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:6243-6253.
37. Swaminham, S., R. Hesselton, J. Sullivan, and E. Kieff. 1993. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J. Virol. 67: 7406-7413.
38. Thäle, R., P. Lucin, K. Schneider, M. Eggers, and U. K. Koszinowski. 1994. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68:7757-7765.
39. Thäle, R., U. Szepan, H. Hengel, G. Geginat, P. Lucin, and U. K. Koszinowski. 1995. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69:6098-6105.
40. Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 258:1369-1372.
41. Ziegler, H., R. Thäle, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farell, W. Rawlinson, and U. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-63.
42. Zsak, L., F. Zuckermann, N. Sugg, and T. Ben-Porat. 1992. Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission. J. Virol. 66:2316-2325.